We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+7.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$71.6B
AUM Growth
+$8.36B
Cap. Flow
+$5.19B
Cap. Flow %
7.25%
Top 10 Hldgs %
7.9%
Holding
3,652
New
433
Increased
1,585
Reduced
1,146
Closed
462

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$468M
2
JNJ icon
Johnson & Johnson
JNJ
+$440M
3
IBM icon
IBM
IBM
+$355M
4
BKNG icon
Booking.com
BKNG
+$332M
5
RAI
Reynolds American Inc
RAI
+$331M

Sector Composition

Rank Sector Weight
1 Healthcare 15.02%
2 Technology 13.31%
3 Financials 12.25%
4 Industrials 9.65%
5 Consumer Staples 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEGG icon
3176
Newegg Commerce
NEGG
$415M
$20K ﹤0.01%
80
-2
-2% -$492
CNXR
3177
DELISTED
Connecture, Inc.
CNXR
$20K ﹤0.01%
+19,002
New +$33.8K
UAMY icon
3178
United States Antimony
UAMY
$736M
$19K ﹤0.01%
37,500
-12,800
-25% -$5.16K
AAU
3179
DELISTED
Almaden Minerals Ltd
AAU
$17K ﹤0.01%
14,900
-2,777
-16% -$3.02K
EVFM
3180
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$17K ﹤0.01%
+119
New +$15.4K
GIGA
3181
DELISTED
Giga-Tronics Inc
GIGA
$15K ﹤0.01%
+19,563
New +$16.6K
TOVX icon
3182
Theriva Biologics
TOVX
$11M
$14K ﹤0.01%
+3
New +$20.9K
YTEN
3183
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$14K ﹤0.01%
+4
New +$14.2K
FNCX
3184
DELISTED
Function(x) Inc.
FNCX
$14K ﹤0.01%
+24,643
New +$38.6K
ASTC icon
3185
Astrotech Corp
ASTC
$17.5M
$13K ﹤0.01%
68
-7
-9% -$1.53K
GLF
3186
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$12K ﹤0.01%
34,900
-278,040
-89% -$320K
URG
3187
Ur-Energy
URG
$537M
$11K ﹤0.01%
+16,400
New +$12.1K
VGZ icon
3188
Vista Gold
VGZ
$339M
$10K ﹤0.01%
+10,300
New +$10.6K
CVM icon
3189
CEL-SCI Corp
CVM
$25.9M
$4K ﹤0.01%
57
-862
-94% -$68.8K
ACIC icon
3190
American Coastal Insurance
ACIC
$465M
-15,300
Closed -$232K
ACLS icon
3191
Axcelis
ACLS
$4.39B
-19,950
Closed -$290K
ACN icon
3192
Accenture
ACN
$110B
-485,410
Closed -$56.9M
AFL icon
3193
Aflac
AFL
$60.5B
-1,173,400
Closed -$40.8M
AFMD
3194
DELISTED
Affimed
AFMD
-5,120
Closed -$92K
AGI icon
3195
Alamos Gold
AGI
$14B
-652,129
Closed -$4.48M
AGO icon
3196
Assured Guaranty
AGO
$3.29B
-237,300
Closed -$8.96M
AIR icon
3197
AAR Corp
AIR
$5.96B
-37,060
Closed -$1.23M
AIZ icon
3198
Assurant
AIZ
$13.9B
-55,100
Closed -$5.12M
AKAM icon
3199
Akamai
AKAM
$17.6B
-600,500
Closed -$40M
AL
3200
DELISTED
Air Lease Corp
AL
-355,600
Closed -$12.2M

Similar funds

Jim Simons's Q1 2017 Portfolio in Review

As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.

  • Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
  • Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
  • Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
  • Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
  • Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
  • Jim Simons opened 433 new positions and closed 462 in Q1 2017.
  • Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.